AI-guided prioritization of potential FAM171A2 ligands through pharmacophore-aware and receptor-based screening
RSC Advances · 2026
DOI: 10.1039/d6ra07609b ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Baihui Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, The Second Affiliated Hospital of Xi'an Jiaotong University 710004 China 13891960816@163.com. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
AI-guided screening combines pharmacophore-aware retrieval, docking and BBB prediction. Two structurally distinct FAM171A2 ligand candidates show favorable docking profiles and stable complexes in molecular dynamics simulations.
Autor:innen und Institutionen
- Department of Anesthesia, The Second Affiliated Hospital of Xi'an Jiaotong University 710004 China 13891960816@163.com.
- Department of Bioengineering, College of Life Science, Dalian Minzu University 116600 China ybh258404025@126.com shaolonglin2023@163.com.
ORCID-Profile: Shaolong Lin
Zitieren
APA
Yan, B., Lu, Y., Tong, Y., Lin, S., & Li, W. (2026). AI-guided prioritization of potential FAM171A2 ligands through pharmacophore-aware and receptor-based screening. RSC Advances. https://doi.org/10.1039/d6ra07609b
Vancouver
Yan B, Lu Y, Tong Y, Lin S, Li W. AI-guided prioritization of potential FAM171A2 ligands through pharmacophore-aware and receptor-based screening. RSC Advances. 2026. doi:10.1039/d6ra07609b
BibTeX
@article{Yan2026,
author = {Yan, Baihui and Lu, Yang and Tong, Yanni and Lin, Shaolong and Li, Wei},
title = {AI-guided prioritization of potential FAM171A2 ligands through pharmacophore-aware and receptor-based screening},
journal = {RSC Advances},
year = {2026},
doi = {10.1039/d6ra07609b}
}
EUVIMED